The village is expected to comprise a demarcated space for the cultivation of medicinal plants, ayurvedic product manufacturing units and a state-of-the-art research centre.
While Kerala has always been synonymous with Ayurveda and countless healing centres, the state will soon have an Ayurvedic village of its own—a first in the country!
Besides tourism, the Ayurveda-centred healthcare sector is one of the biggest revenue generators in the tropical region, and after thoroughly exploring this idea, the state government is now looking to establish a dedicated Ayurvedic village.
Alongside this initiative, the initiation of clinical and molecular studies by Oushadhi, a manufacturing company believed to be the largest producer of ayurvedic medicines in India, is also in the pipeline.
“The ayurvedic village is perhaps the first of its kind in the country. The state government has already submitted a proposal for the same to the Ministry of AYUSH, and a response is awaited,” said KR Viswambharan, the chairman of Oushadhi to The New Indian Express.
He further mentioned that the village would comprise a demarcated space for the cultivation of medicinal plants, ayurvedic product manufacturing units and a state-of-the-art research centre. The concerned authorities have predicted that these initiatives will help to boost the already mushrooming export of ayurvedic products.
To give wings to the project, Oushadhi has approached the Kerala State Industrial Development Corporation with the request of allocating funds for the research facilities. Additionally, to aid their research and development activities, talks with the Confederation for Ayurvedic Renaissance-Keralam Ltd at Koratty, Thrissur, are underway.
Through its molecular research programme, what the organisation intends to achieve is a standard that could prove the authenticity of medicinal products—a step that could become a game-changer for the Ayurvedic healthcare industry and export sales.
“At present ayurvedic products are exported as nutraceuticals, health supplements or dietary supplements. What we plan to do is to sell these products in the international market as a therapeutic medicine, but for that, we have to undertake clinical and molecular studies, which at present is almost absent in the sector,” added Viswambharan.
(Edited by Gayatri Mishra)